Skip to main content
Caplight Logo









Origin Genomics

Origin Genomics

Private
New York City, New YorkHealthcare & Life Scienceshttps://origingenomics.com/

Company Overview

Origin Genomics is a biotechnology company that develops precision germline gene correction technologies to address severe inherited diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

germline gene correctiongene editingmitochondrial replacement therapyMRTprecision medicineinherited diseasegenetic engineeringdesigner babiesgenomicsbiotechnologybioinformaticsrare disease treatmentreproductive medicinegene therapyembryology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origin Genomics Comparables

Compare Origin Genomics with similar companies based on industry and business-model similarity.

Origin Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Preventive
90%
Tessera Therapeutics
58%
Beam Therapeutics
54%

Origin Genomics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Cathy Tie

CEO and Founder

Founding Team

Origin Genomics Filings

Explore SEC and related filing metadata, where available.

Origin Genomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Origin Genomics's valuation, stock price, and market status.

Is Origin Genomics a public or private company?

Origin Genomics is a private company.

What is the current stock price of Origin Genomics?

Origin Genomics is a private company with no public stock price. No recent secondary market data is available.

How much is Origin Genomics worth (valuation)?

Valuation information for Origin Genomics is not publicly available.

Can I buy Origin Genomics stock?

Origin Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Origin Genomics's last funding round?

Funding round information for Origin Genomics is not publicly available.

Who are the main investors in Origin Genomics?

Investor information for Origin Genomics is not publicly disclosed.

Will Origin Genomics IPO soon?

No public IPO plans have been announced for Origin Genomics.

How can I track Origin Genomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Origin Genomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range1
Year Founded2026
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?